Aikaterini Anagnostou, MD, PhD
As Director of the Food Immunotherapy Program, Dr. Anagnostou is passionate about investigating new and innovative treatments for food allergy. She obtained her PhD from Cambridge University in the United Kingdom and her dissertation focused on two separate trials of Peanut Oral Immunotherapy in children. Her research work was published in The Lancet and received international recognition.
Dr. Anagnostou has developed a strong interest in preventing and treating all forms of allergic disease. She is committed to improving the quality of life of allergic patients and their families.
Dr. Anagnostou studied Medicine at Aristotle University and graduated with First Class Honors in 2000. She trained in Pediatrics at Addenbrooke’s Hospital, Cambridge and at Great Ormond Street Hospital and the Royal Brompton Hospital, London. Prior to her appointment as Associate Professor at Texas Children’s Hospital, she worked as a Pediatric Allergist in the Children’s Allergy Unit at St Thomas’ Hospital in London.
View News Articles:
Anagnostou K, Islam S, King Y, Foley L,Pasea L, Bond S, Palmer C, Deighton J,Ewan P, Clark A. Assessing the efficacy of oral immunotherapy for the desensitization of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. The Lancet 2014 Apr 12;383(9925):1297-304.
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.